BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis. 2000;18:20-26. [PMID: 10729734 DOI: 10.1159/000016930] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Budzyński J, Kłopocka M, Pulkowski G, Suppan K, Fabisiak J, Majer M, Swiatkowski M. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial. Int J Cardiol 2008;127:233-9. [PMID: 17689732 DOI: 10.1016/j.ijcard.2007.04.079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
2 Varannes SBD, Sacher-Huvelin S, Vavasseur F, Masliah C, Rhun ML, Aygalenq P, Bonnot-Marlier S, Lequeux Y, Galmiche JP. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: Results of a study in a primary care setting. World J Gastroenterol 2006; 12(16): 2569-2573 [PMID: 16688803 DOI: 10.3748/wjg.v12.i16.2569] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
3 Dickman R, Fass R. Ambulatory Esophageal pH Monitoring: New Directions. Dig Dis 2006;24:313-8. [DOI: 10.1159/000092885] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
4 Chun BJ, Lee DS. The effect of itopride combined with lansoprazole in patients with laryngopharyngeal reflux disease. Eur Arch Otorhinolaryngol. 2013;270:1385-1390. [PMID: 23292040 DOI: 10.1007/s00405-012-2341-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
5 Locke G. Natural history of nonerosive reflux disease. Gastroenterology Clinics of North America 2002;31:S59-66. [DOI: 10.1016/s0889-8553(02)00040-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Fass R, Achem SR. Noncardiac chest pain: diagnostic evaluation. Dis Esophagus 2012;25:89-101. [PMID: 21777340 DOI: 10.1111/j.1442-2050.2011.01225.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
7 Wong WM, Fass R. Extraesophageal and atypical manifestations of GERD. J Gastroenterol Hepatol. 2004;19 Suppl 3:S33-S43. [PMID: 15324380 DOI: 10.1111/j.1440-1746.2004.03589.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004;53 Suppl 4:iv1-i24. [PMID: 15082609 DOI: 10.1136/gut.2003.034272] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
9 Vaezi MF, Pandolfino JE, Vela MF, Shaheen NJ. White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology 2017;15:1162-72. [DOI: 10.1016/j.cgh.2017.03.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Gasiorowska A, Fass R. The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol 2008;42:867-74. [PMID: 18645525 DOI: 10.1097/MCG.0b013e31816c47ed] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
11 Durazzo M, Lupi G, Cicerchia F, Ferro A, Barutta F, Beccuti G, Gruden G, Pellicano R. Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update. J Clin Med 2020;9:E2559. [PMID: 32784573 DOI: 10.3390/jcm9082559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Naik RD, Vaezi MF. Recent advances in diagnostic testing for gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol 2017;11:531-7. [PMID: 28317452 DOI: 10.1080/17474124.2017.1309286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Locke GR 3rd. Current medical management of gastroesophageal reflux disease. Thorac Surg Clin 2005;15:369-75. [PMID: 16104127 DOI: 10.1016/j.thorsurg.2005.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Ali T, Miner PB. New developments in gastroesophageal reflux disease diagnosis and therapy: . Current Opinion in Gastroenterology 2008;24:502-8. [DOI: 10.1097/mog.0b013e3283025c6d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Wong WM, Wong BC. Definition and diagnosis of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004;19 Suppl 3:S26-32. [PMID: 15324379 DOI: 10.1111/j.1440-1746.2004.03588.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
16 Tierney WS, Gabbard SL, Milstein CF, Benninger MS, Bryson PC. Treatment of laryngopharyngeal reflux using a sleep positioning device: A prospective cohort study. American Journal of Otolaryngology 2017;38:603-7. [DOI: 10.1016/j.amjoto.2017.06.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yang J, Lee J, Lee H, Lee J, Youn YM, Choi JH, Kim YJ, Kang HS, Han KH, Kim SH, Kang KS. Is the Diagnostic Trial with Proton Pump Inhibitors Reasonable for School Age Children with Gastroesophageal Reflux Symptoms? Pediatr Gastroenterol Hepatol Nutr 2019;22:511-7. [PMID: 31777716 DOI: 10.5223/pghn.2019.22.6.511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Tutuian R, Castell DO. Management of gastroesophageal reflux disease. Am J Med Sci 2003;326:309-18. [PMID: 14615672 DOI: 10.1097/00000441-200311000-00007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
19 Dickman R, Mattek N, Holub J, Peters D, Fass R. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol. 2007;102:1173-1179. [PMID: 17378910 DOI: 10.1111/j.1572-0241.2007.01117.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
20 Lacy BE, Weiser K, Chertoff J, Fass R, Pandolfino JE, Richter JE, Rothstein RI, Spangler C, Vaezi MF. The Diagnosis of Gastroesophageal Reflux Disease. The American Journal of Medicine 2010;123:583-92. [DOI: 10.1016/j.amjmed.2010.01.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 58] [Article Influence: 7.5] [Reference Citation Analysis]
21 Fass R, Malagon I, Schmulson M. Chest pain of esophageal origin: . Current Opinion in Gastroenterology 2001;17:376-80. [DOI: 10.1097/00001574-200107000-00013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
22 Li J, Zhang L, Zhang C, Cheng JY, Li J, Jeff Cheng C. Linguistic Adaptation, Reliability, Validation, and Responsivity of the Chinese Version of Reflux Symptom Index. Journal of Voice 2016;30:104-8. [DOI: 10.1016/j.jvoice.2013.12.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
23 Bak YT. Management strategies for gastroesophageal reflux disease. J Gastroenterol Hepatol 2004;19 Suppl 3:S49-53. [PMID: 15324382 DOI: 10.1111/j.1440-1746.2004.03587.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
24 Radaelli F, Strocchi E, Passaretti S, Strada E, Frego R, Dinelli M, Fossati D, Barzaghi F, Limido E, Bortoli A, Della Casa D, Missale G, Snider L, Noris R, Viviani G, Minoli G. Is esophageal pH monitoring used appropriately in an open-access system? A prospective multicenter study. Am J Gastroenterol 2004;99:2115-20. [PMID: 15554989 DOI: 10.1111/j.1572-0241.2004.40175.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
25 Cohen H, Moraes-Filho JP, Cafferata ML, Tomasso G, Salis G, González O, Valenzuela J, Sharma P, Malfertheiner P, Armstrong D, Lundell L, Corti R, Sakai P, Ceconello I; Latin-American GORD Consensus Group. An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2006;18:349-68. [PMID: 16538106 DOI: 10.1097/00042737-200604000-00008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Quigley E, Dibaise J. Non-erosive reflux disease: the real problem in gastro-oesophageal reflux disease. Digestive and Liver Disease 2001;33:523-7. [DOI: 10.1016/s1590-8658(01)80100-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
27 Dickman R, Emmons S, Cui H, Sewell J, Hernández D, Esquivel RF, Fass R. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2005;22:547-55. [PMID: 16167971 DOI: 10.1111/j.1365-2036.2005.02620.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
28 Gómez-Escudero O, Coss-Adame E, Amieva-Balmori M, Carmona-Sánchez RI, Remes-Troche JM, Abreu Y Abreu AT, Cerda-Contreras E, Gómez-Castaños PC, González-Martínez MA, Huerta-Iga FM, Ibarra-Palomino J, Icaza-Chávez ME, López-Colombo A, Márquez-Murillo MF, Mejía-Rivas M, Morales-Arámbula M, Rodríguez-Chávez JL, Torres-Barrera G, Valdovinos-García LR, Valdovinos-Díaz MA, Vázquez-Elizondo G, Villar-Chávez AS, Zavala-Solares M, Achem SR. The Mexican consensus on non-cardiac chest pain. Rev Gastroenterol Mex (Engl Ed) 2019;84:372-97. [PMID: 31213326 DOI: 10.1016/j.rgmx.2019.05.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668-685. [PMID: 17335450 DOI: 10.1111/j.1572-0241.2006.00936.x] [Cited by in Crossref: 259] [Cited by in F6Publishing: 192] [Article Influence: 18.5] [Reference Citation Analysis]
30 Bautista J, Fullerton H, Briseno M, Cui H, Fass R. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2004;19:1123-30. [PMID: 15142202 DOI: 10.1111/j.1365-2036.2004.01941.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
31 Baldi F. Diagnostic strategy in patients with extraesophageal GERD. Curr Gastroenterol Rep 2002;4:99-100. [PMID: 11900673 DOI: 10.1007/s11894-002-0043-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Durazzo M, Gargiulo G, Pellicano R. Non-cardiac chest pain: a 2018 update. Minerva Cardioangiol 2018;66. [DOI: 10.23736/s0026-4725.18.04681-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
33 Marambaia O, Andrade NA, Varela D, Juncal M. Refluxo laringofaringeano: estudo prospectivo correlacionando achados laringoscópicos precoces com a phmanometria de 24 horas de 2 canais. Rev Bras Otorrinolaringol 2002;68:527-31. [DOI: 10.1590/s0034-72992002000400012] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
34 Yuksel ES, Vaezi MF. Therapeutic strategies for laryngeal manifestations of gastroesophageal reflux disease. J Clin Gastroenterol. 2013;47:195-204. [PMID: 23340061 DOI: 10.1097/mcg.0b013e31827458f9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
35 Schey R, Alla S, Midani D, Parkman H. Recurrencia sintomática relacionada con la enfermedad por reflujo gastroesofágico en pacientes que descontinúan los inhibidores de la bomba de protones durante el estudio inalámbrico de monitorización de pH esofágico Bravo ®. Revista de Gastroenterología de México 2017;82:277-86. [DOI: 10.1016/j.rgmx.2016.12.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Bruley des Varannes S. The proton-pump inhibitor test: pros and cons. Eur J Gastroenterol Hepatol. 2004;16:847-852. [PMID: 15316406 DOI: 10.1097/00042737-200409000-00005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
37 Eslick GD, Fass R. Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am. 2003;32:531-552. [PMID: 12858605 DOI: 10.1016/S0889-8553(03)00029-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
38 Fass R. Sensory Testing of the Esophagus. Journal of Clinical Gastroenterology 2004;38:628-41. [DOI: 10.1097/01.mcg.0000128989.13808.95] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
39 Ciecierega T, Gordon BL, Aronova A, Crawford CV, Zarnegar R. More art than science: impedance analysis prone to interpretation error. J Gastrointest Surg. 2015;19:987-992. [PMID: 25876531 DOI: 10.1007/s11605-015-2809-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
40 Pettit M. Gastroesophageal reflux disease: clinical features. Pharm World Sci 2005;27:417-20. [PMID: 16341946 DOI: 10.1007/s11096-005-7116-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
41 Numans ME, de Wit NJ. Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastro-oesophageal reflux disease questionnaire. Aliment Pharmacol Ther 2003;17:1049-55. [PMID: 12694087 DOI: 10.1046/j.1365-2036.2003.01549.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
42 Boparai V, Rajagopalan J, Triadafilopoulos G. Guide to the Use of Proton Pump Inhibitors in Adult Patients: . Drugs 2008;68:925-47. [DOI: 10.2165/00003495-200868070-00004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
43 Wong WM, Bautista J, Dekel R, Malagon IB, Tuchinsky I, Green C, Dickman R, Esquivel R, Fass R. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring--a randomized trial. Aliment Pharmacol Ther. 2005;21:155-163. [PMID: 15679765 DOI: 10.1111/j.1365-2036.2005.02313.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 73] [Article Influence: 5.9] [Reference Citation Analysis]
44 Marambaia O, Andrade NA, Varela D, Juncal M. Refluxo laringofaringeano: estudo prospectivo correlacionando achados laringoscópicos precoces com a pHmanometria de 24 horas de 2 canais. Rev Bras Otorrinolaringol 2002;68:81-5. [DOI: 10.1590/s0034-72992002000100014] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Shin MH, Nam SY, Park YH, Son YI. Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux. Clin Exp Otorhinolaryngol 2012;5:28-33. [PMID: 22468199 DOI: 10.3342/ceo.2012.5.1.28] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]